In vivo distribution and cellular uptake mechanism of targeting self-assembling peptide delivery systems: Dominant role of targeting ligands and modulatory effect of self-assembling moieties
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Supramolecular Self-Assembly in Materials · Chemical Synthesis and Analysis · RNA Interference and Gene Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (46)
Show source-provided references
1. Therapeutic peptides, proteins and their nanostructures for drug delivery and precision medicine10.1002/cbic.202300831 ↗
2. Cell-mediated and peptide-based delivery systems: emerging frontiers in targeted therapeutics10.3390/pharmaceutics17121597 ↗
3. Peptide-functionalized nanomedicine: advancements in drug delivery
4. Functional peptides in targeted cancer therapy: mechanisms, delivery strategies, and clinical perspectives10.1007/s10989-025-10748-5 ↗
5. A comprehensive review of HER2 in cancer biology and therapeutics10.3390/genes15070903 ↗
6. HER2-positive gastric cancer and antibody treatment: state of the art and future developments10.3390/cancers16071336 ↗
7. Combination therapy of trastuzumab and lapatinib in chemorefractory HER2-positive metastatic colorectal cancer: an efficacy and safety analysis10.3923/ijp.2025.369.377 ↗
8. Lapatinib and lapatinib plus trastuzumab therapy versus trastuzumab therapy for HER2 positive breast cancer patients: an updated systematic review and meta-analysis10.1186/s13643-022-02134-9 ↗
9. Adverse effects of tyrosine kinase inhibitors in cancer therapy: pathophysiology, mechanisms and clinical management10.1038/s41392-023-01469-6 ↗
10. Improved tumor penetration and single-cell targeting of antibody-drug conjugates increases anticancer efficacy and host survival10.1158/0008-5472.CAN-17-1638 ↗
11. Co-administered antibody improves penetration of antibody-dye conjugate into human cancers with implications for antibody-drug conjugates10.1038/s41467-020-19498-y ↗
12. Tyrosine kinase inhibitors in HER2-positive metastatic breast cancer with trastuzumab emtansine resistance: insights from a multicenter retrospective real-world study10.1002/mco2.624 ↗
13. Peptide-based nanomaterials: self-assembly, properties and applications
14. Peptide-based nanomaterials: self-assembly and applications10.2174/1389557522666220819103907 ↗
15. Rationally designed anti-HER2/neu peptide mimetic disables P185HER2/neu tyrosine kinases in vitro and in vivo10.1038/72651 ↗
16. Transformable peptide nanoparticles arrest HER2 signalling and cause cancer cell death in vivo10.1038/s41565-019-0626-4 ↗
17. Transformable peptide nanoparticles arrest HER2 signalling and cause cancer cell death in vivo10.1038/s41565-019-0626-4 ↗
18. Self-assembling peptides: from design to biomedical applications10.3390/ijms222312662 ↗
19. Structure of the cross-beta spine of amyloid-like fibrils10.1038/nature03680 ↗
20. Molecular insights into the dynamics of amyloid fibril growth: elongation and lateral assembly of GNNQQNY protofibrils10.1021/acschemneuro.3c00754 ↗
21. Prion-like aggregation of the heptapeptide GNNQQNY into amyloid nanofiber is governed by configuration entropy10.1021/acs.jcim.3c00370 ↗
22. Systemic study on anti-tumor activity of HER2 induced peptide-drug conjugate clustering in xenograft tumor models10.1016/j.cclet.2025.111257 ↗
23. Bioinspired cell-derived nanovesicles versus exosomes as drug delivery systems: a cost-effective alternative10.1038/s41598-017-14725-x ↗
24. How Do Biomolecules Cross the Cell Membrane?10.1021/acs.accounts.1c00560 ↗
25. Progress in peptide and protein therapeutics: challenges and strategies10.1016/j.apsb.2025.10.026 ↗
26. Boyette Lc Fau · 2023
27. Structure, Functional Assessment, and Blood Flow of the Liver
28. Dalal · 2025
29. Rapid precision targeting of nanoparticles to lung via caveolae pumping system in endothelium10.1038/s41565-024-01786-z ↗
30. Engineering supramolecular peptide nanofibers for in vivo platelet-hitchhiking beyond ligand-receptor recognition10.1126/sciadv.adq2072 ↗
31. Decoration of gold nanoparticles with glycopeptides leads to a lower cellular uptake and liver retention10.1039/D5NA00464K ↗
32. Targeting polymeric nanoparticles to specific cell populations in the liver10.1021/acs.biochem.4c00712 ↗
33. Recognition of HER2 expression in hepatocellular carcinoma and its significance in postoperative tumor recurrence10.1002/cam4.2006 ↗
34. HGF/c-Met: a key promoter in liver regeneration
35. Multiple blockades of the HGF/Met signaling pathway for metastasis suppression using nanoinhibitors10.1021/acsami.1c07010 ↗
36. Understanding nanoparticle-liver interactions in nanomedicine10.1080/17425247.2024.2375400 ↗
37. Steric hindrance effect as a decisive factor for the self-assembly of metallocages10.1021/acs.inorgchem.3c00026 ↗
38. Protein corona hampers targeting potential of MUC1 aptamer functionalized SN-38 core-shell nanoparticles10.1016/j.ijpharm.2015.08.060 ↗
39. Controlling evolution of protein corona: a prosperous approach to improve chitosan-based nanoparticle biodistribution and half-life10.1038/s41598-020-66572-y ↗
40. Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats10.2217/17435889.3.5.703 ↗
41. Shape effects of filaments versus spherical particles in flow and drug delivery10.1038/nnano.2007.70 ↗
42. Quantitative fluorescence spectroscopy and flow cytometry analyses of cell-penetrating peptides internalization pathways: optimization, pitfalls, comparison with mass spectrometry quantification10.1038/srep36938 ↗
43. Self-assembling protein nanoparticles for cytosolic delivery of nucleic acids and proteins
44. Self-assembling peptide with dual function of cell penetration and antibacterial as a nano weapon to combat intracellular bacteria10.1126/sciadv.ads3844 ↗
45. Inhalable SPRAY nanoparticles by modular peptide assemblies reverse alveolar inflammation in lethal Gram-negative bacteria infection10.1126/sciadv.ado1749 ↗
46. Enhanced plasma half-life and efficacy of engineered human albumin-fused GLP-1 despite enzymatic cleavage of its C-terminal end10.1038/s42003-025-08249-8 ↗